Medicinal Flavor of Fecal Microbiota and Efficacies of Its Transplantation in Mice with Different Types of Ulcerative Colitis
1. Graduate School, Jiangxi University of Chinese Medicine, Nanchang 330004, China 2. Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang 330046, China 3. School of Basic Medical Sciences, Jiangxi University of Chinese Medicine, Nanchang 330004, China
MA X F, HU J L, CUI M M, et al. Medicinal flavor of fecal microbiota and efficacies of its transplantation in mice with different types of ulcerative colitis[J]. Chinese General Practice, 2022, 25 (15) : 1875-1882.
Xiaofei MA,Jiali HU,Manman CUI, et al. Medicinal Flavor of Fecal Microbiota and Efficacies of Its Transplantation in Mice with Different Types of Ulcerative Colitis[J]. Chinese General Practice, 2022, 25(15): 1875-1882. DOI: 10.12114/j.issn.1007-9572.2022.02.025.
马晓飞,胡家丽,崔曼曼等. 粪菌移植对不同溃疡性结肠炎小鼠的疗效及其中药性味研究[J]. 中国全科医学, 2022, 25(15): 1875-1882. DOI: 10.12114/j.issn.1007-9572.2022.02.025.
PERMPOONV, PONGPIRULK, ANURASS. Ethnic variations in ulcerative colitis:experience of an international hospital in Thailand[J]. World J Gastrointest Pharmacol Ther,2016,7(3):428-433. DOI:10.4292/wjgpt.v7.i3.428.
[2]
ZHENJ H, HUANGG R. Etiology and pathogenesis of ulcerative colitis from the perspective of modern medicine[J]. World Chin J Dig,2019,27(4):245-251. DOI:10.11569/wcjd.v27.i4.245.
[3]
KHORUTSA, WEINGARDENA R. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology[J]. Immunol Lett,2014,162(2 Pt A):77-81. DOI:10.1016/j.imlet.2014.07.016.
[4]
SUNGM K, PARKM Y. Nutritional modulators of ulcerative colitis:clinical efficacies and mechanistic view[J]. World J Gastroenterol,2013,19(7):994-1004. DOI:10.3748/wjg.v19.i7.994.
[5]
DA SILVAB C, LYRAA C, ROCHAR,et al. Epidemiology,demographic characteristics and prognostic predictors of ulcerative colitis[J]. World J Gastroenterol,2014,20(28):9458-9467. DOI:10.3748/wjg.v20.i28.9458.
[6]
FORDA C, BERNSTEINC N, KHANK J,et al. Glucocorticosteroid therapy in inflammatory bowel disease:systematic review and meta-analysis[J]. Am J Gastroenterol,2011,106(4):590-599;quiz600. DOI:10.1038/ajg.2011.70.
[7]
SURAWICZC M, BRANDTL J, BINIOND G,et al. Guidelines for diagnosis,treatment,and prevention of Clostridium difficile infections[J]. Am J Gastroenterol,2013,108(4):478-498;quiz499. DOI:10.1038/ajg.2013.4.
[8]
CAMMAROTAG, PECERES, IANIROG,et al. Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases[J]. Dig Dis,2016,34(3):279-285. DOI:10.1159/000443362.
WEIY, GONGJ F, ZHUW M,et al. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora[J]. BMC Microbiol,2016,16(1):255. DOI:10.1186/s12866-016-0869-2.
[13]
ZHUQ, ZHENGP F, ZHOUJ Y,et al. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patients[J]. Mol Med Rep,2018,18(1):622-626. DOI:10.3892/mmr.2018.8992.
[14]
XUEB, LIUX L, DONGW W,et al. EGCG maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-κB signaling pathway in rats[J]. Can J Gastroenterol Hepatol,2017,2017:3057268. DOI:10.1155/2017/3057268.
[15]
CAYZERC, PATELK, WANGX,et al. Effect of probiotics on Th1 and Th2 cytokines:relevance to pathogenesis and treatment of ulcerative colitis[J]. J Gastroenterol Hepatol,2001,16:36. DOI:10.1111/j.1440-1746.2001.ca01-36.x.
[16]
ANDREWSH, BARCZAKP, ALLANR N. Psychiatric illness in patients with inflammatory bowel disease[J]. Gut,1987,28(12):1600-1604. DOI:10.1136/gut.28.12.1600.